Clinical Outcomes and Quality of Life in Children with Central Precocious Puberty: A Pragmatic Analysis

Parikshit Sen1, Aashima Dabas1, Ravindra Kumar2

  • 1Department of Pediatrics, Maulana Azad Medical College and Lok Nayak Hospital, New Delhi, India.

Insights

Central precocious puberty (CPP) treatment with gonadotropin releasing hormone analog (GnRHa) leads to favorable growth and normal puberty resumption. Early GnRHa therapy is linked to better quality of life outcomes in children with CPP.

Area of Science:

  • Pediatric Endocrinology
  • Reproductive Medicine
  • Child Growth and Development

Background:

  • Central precocious puberty (CPP) presents variable growth and pubertal outcomes influenced by treatment. Understanding these outcomes is crucial for optimizing therapeutic strategies.
  • Assessing the impact of gonadotropin releasing hormone analog (GnRHa) therapy on anthropometric measures and pubertal progression in children with CPP is essential.

Purpose of the Study:

  • To evaluate growth and pubertal progression in children with CPP undergoing GnRHa therapy.
  • To correlate treatment outcomes with the quality of life in children with CPP.

Main Methods:

  • An observational study involving children with CPP treated with GnRHa.
  • Collection of baseline and follow-up clinical data, including anthropometric measurements and pubertal status.
  • Quality of life assessment using the PedsQL 4.0 questionnaire at the final follow-up visit.

Main Results:

  • A cohort of 23 children (21 girls, 2 boys) with CPP was studied, with a median follow-up of 4.4 years.
  • Treatment completion resulted in normal pubertal progression for 12 children. The bone age to chronological age ratio significantly decreased (p < 0.001).
  • Earlier GnRHa therapy initiation correlated with improved growth velocity (r = -0.598; p = 0.003). Quality of life scores were generally favorable but lower in shorter, older, or post-menarcheal girls.

Conclusions:

  • GnRHa therapy leads to favorable anthropometric outcomes and normal puberty resumption in children with CPP.
  • Early and adequate GnRHa treatment is associated with positive quality of life outcomes in this pediatric population.
Abstract

Related Concept Videos

Signs of Puberty01:27

Signs of Puberty

Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
196
Adrenal Gland Disorders01:27

Adrenal Gland Disorders

Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
1.3K
Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
20.3K
Conduct Disorder01:28

Conduct Disorder

Conduct disorder is a complex mental health diagnosis characterized by a repetitive and persistent pattern of behavior that violates societal norms, the rights of others, or age-appropriate rules. The diagnostic criteria for conduct disorder require the presence of at least three problematic behaviors within the past 12 months, with at least one occurring in the past six months. These behaviors are grouped into four categories: aggression toward people and animals; destruction of property;...
23
Socioemotional Experience and Gender Development01:30

Socioemotional Experience and Gender Development

Social-emotional experiences and cultural influences play significant roles in shaping gender development. During middle childhood, from ages 6 to 11, peer groups become dominant in reinforcing gender norms. Children in this age group often align with same-gender peer groups, which actively encourage behaviors that conform to traditional gender roles. For instance, boys may be discouraged from engaging in activities perceived as feminine, reinforcing culturally dictated norms about masculinity...
21
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
34